Novartis wins US OK for biosimilar version of Amgen’s Enbrel Aug 30th

How to go about securing the best policy for your insurance in Canada.
Latest News

“How can I lower my auto insurance bill during COVID-19 lockdown?” + MORE May 3rd

On April 8, 2020, the Insurance Bureau of Canada released the following statement: To help Canadians cope with the financial impact of COVID-19, the Insurance Bureau of Canada (IBC) member companies are offering substantial consumer relief measures. For consumers whose driving habits have changed si.... More »
 term insurance

When two people are on a condo title, who pays capital gains? Aug 27th

Q. I purchased a condo in Saskatchewan in 2001. I was young, and because I had a lower income than usual that year, my father co-signed for the mortgage. If I sell the condo with my dad on the title, will he be subject to the capital gains tax? And if so, can I get him off the title prior to a pote.... More »

Here’s when you might be able to apply for lower property taxes Aug 8th

Owning a home comes with a long list of expenses that go beyond a monthly mortgage, whether that’s replacing an old roof, paying for home insurance, or keeping up with climbing property taxes. While many costs are fixed, experts say there might be some wiggle room on property taxes to get the .... More »

Does driving school lower insurance for Canadian drivers? Nov 16th

When you’re a new driver, insurance companies view you as being at higher risk of accidents than someone who’s been on the road for several decades. The risk of collision is highest within the first year a driver is on the road, and it decreases as drivers gain more experience. As a result, new .... More »

Can you gain entry to your formerly shared home after a separation? May 7th

Q. I have somewhat of a complicated situation regarding my separation and the separation agreement, so I’ll try my best to give you as much information as possible: February 2004: Partner and I started living together. He had just purchased a townhouse with financial assistance from his mother. I.... More »
U.S. regulators have approved the first near-copy of Enbrel, drugmaker Amgen’s pricey biologic medicine for treating rheumatoid arthritis and other immune system disorders.
The follow-up version of Enbrel, dubbed Erelzi, was developed by Swiss drug giant Novartis, which would not disclose the planned list price for Erelzi.
Novartis also couldn’t say when the new medicine will be launched by its Sandoz unit, which makes generic drugs and “biosimilars” — nearly identical versions of biologic drugs produced in living cells.
Erelzi is the third biosimilar drug approved by the Food and Drug Administration. It’s also the second approved biosimilar developed by Novartis, and the second that will compete with an Amgen drug.
Enbrel was first approved in 1998. It can cost about $4,000 per month without insurance.
The post Novartis wins US OK for biosimilar version of Amgen’s Enbrel appeared first on Canadian Business – Your Source For Business News.

Continue Reading On canadianbusiness.com »

Share

PinIt
Compare insurance quotes through Kanetix.ca - save time and money!